NOVOZYMES A/S: Financial statements 2019
CVR: 10007127
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
NOVOZYMES A/S (CVR 10007127) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 14,374,000,000 and a net result of DKK 3,155,000,000 compared with DKK 3,227,000,000 the year before. That is a decrease of 0.1% compared with the year before. The profit margin was 21.9%. Equity in the 2019 report amounted to DKK 11,480,000,000. The solvency ratio was 56.2%.
- Revenue
- DKK 14,374,000,000
- Gross Profit
- DKK 7,954,000,000
- Profit/Loss
- DKK 3,155,000,000
- Equity
- DKK 11,480,000,000
- Total Assets
- DKK 20,437,000,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 14.4B | 8B | 3.2B | 11.5B | - |
| 2018 | 14.4B | 8.3B | 3.2B | 11.4B | - |
| 2017 | 14.5B | 8.4B | 3.1B | 11.3B | - |
| 2016 | 14.1B | 8.1B | 3.1B | 11.7B | - |
| 2015 | 14B | 8.1B | 2.8B | 11.6B | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
NOVOZYMES A/S has published its interim report for the period January 1, 2019 to September 30, 2019.
NOVOZYMES A/S has published its interim report for the period January 1, 2019 to June 30, 2019.
As of September 1, 2019, Lars Green is registered as director of NOVOZYMES A/S.
As of August 9, 2019, Lars Green has left the board of directors of NOVOZYMES A/S.
As of August 8, 2019, Prisca Havranek-Kosicek has stepped down as director of NOVOZYMES A/S.
NOVOZYMES A/S has published its interim report for the period January 1, 2019 to March 31, 2019.
NOVOZYMES A/S has published its annual report for 2018. Revenue came to DKK 14,390,000,000, and the net result was DKK 3,227,000,000.
As of January 31, 2019, Patricia Malarkey has left the board of directors of NOVOZYMES A/S.
About NOVOZYMES A/S
NOVOZYMES A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2000. The company is registered under the industry Fremstilling af andre organiske basiskemikalier. The management consists of Ester Baiget Arnau and Rainer Chapour Lehmann. The board consists of Cornelis de Jong (chair), Heine Dalsgaard, Frederikke Rose Spenner and Kasim Kutay. The company is owned by Novo Holdings A/S and BlackRock, Inc.. The company has 3,508 employees (2026). In 2025, the company reported revenue of EUR 4,157,600,000 and a net result of EUR 583,600,000 compared with EUR 305,800,000 the year before. Equity in the 2025 report amounted to EUR 10,855,200,000.